In a recent survey, 42 percent of people taking CBD said that they had stopped taking traditional medications, including pain-killers and stronger prescription pain killers after successfully transitioning to CBD. This is hopeful news in an era seeing an epidemic in opioid overdoses, the addiction to which often begins with prescription opioids.
“We are seeing an exponential rise in the interest of CBD products from our patient community—particularly among women,” said Dr. Perry Solomon, the chief medical officer of HelloMD “While we still have much to learn, we cannot ignore this one fact; the majority of those using CBD products today receive great benefit. This has the potential for far-reaching consequences.”
The survey, which was conducted by Brightfield Group and HelloMD, covering 2,400 of HelloMD’s 150,000-strong membership, also brought forth other relevant information about CBD usage. Notably, the study found that 55 percent of CBD users were women, while men often preferred products that were THC-dominant. Research has shown previously that women reportedly use cannabis less than men, and the contrast in women preferring CBD, a cannabinoid that can help ease pain and a variety of other symptoms but missing the mind-altering effects of THC, is an interesting one that researchers will hopefully look further into.
Other findings in the study include that the most common reasons for use of it include insomnia, depression, anxiety and joint pain, and showed that eighty percent of users found it to be “very or extremely effective” for their treatment, with only three percent stating that they noticed no difference.
Bethany Gomez, director of research for Brightfield Group stated, “This study is exciting because it shows there is potentially a huge barely-tapped market for CBD products that could improve the lives of many people. With further research and public education, it could be an effective alternative treatment for many people, particularly at a time when our nation is in the midst of an opioid crisis.”
CBD is looking to have a bright future, and while much research is needed, it’s fair to say that it, and other cannabinoid products, might have a place in the fight against the opioid epidemic.